Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows the addition of Revision: v3.4.2 and the deletion of Revision: v3.4.1 as part of a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page footer, indicating a small page update.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary toggle added; 'Last Update Submitted that Met QC Criteria' label updated; 'No FEAR Act Data' note added; and the site revision updated to v3.4.0. These are UI/metadata updates that do not alter the study information.SummaryDifference0.1%

- Check42 days agoChange DetectedMinor update to site revision from v3.3.3 to v3.3.4 with no other observed changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations updated: new sites added across multiple states and several existing sites removed, as shown in Revision: v3.3.3.SummaryDifference0.9%

- Check91 days agoChange DetectedUpdated the Publications section description to say PubMed-listed publications are automatically populated for the study and may not all pertain to it. Updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.